Form 4: GoodRx Holdings Director Rey-Giraud Acquires Shares
SEC Form 4 Filing
Agnes Rey-Giraud, a director of GoodRx Holdings, acquired 2,464 shares of Class A Common Stock on July 8, 2024.
Summary
- On July 8, 2024, Agnes Rey-Giraud, a director of GoodRx Holdings, Inc., acquired 2,464 shares of Class A Common Stock.
- The acquisition was made at a price of $0 per share.
- Following the transaction, Rey-Giraud directly owns 103,617 shares of Class A Common Stock.
- The transaction also involved restricted stock units that vest in full on the earlier of June 6, 2025, and the date of the 2025 Annual Meeting of Stockholders, subject to continued service.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a standard regulatory filing indicating a director's stock acquisition, which can be interpreted as a slightly positive sign of confidence, but it's not overwhelmingly bullish.
Positives
- The acquisition of shares by a director can be seen as a positive signal, indicating confidence in the company's future prospects.
Future Outlook
The document does not contain specific forward-looking statements, but the vesting of restricted stock units in 2025 suggests a continued service requirement for the director.
Industry Context
Form 4 filings are routine disclosures required by the SEC to ensure transparency in insider trading activities. They provide insights into the actions of company insiders, such as directors and officers, and their confidence in the company's stock.
Comparison to Industry Standards
- Comparing insider activity at GoodRx to similar companies like Teladoc Health (TDOC) or CVS Health (CVS) can provide a broader context.
- Analyzing the frequency and size of insider transactions across these companies can reveal whether GoodRx's insiders are more or less bullish than their peers.
- Benchmarking the vesting schedules of restricted stock units against industry norms can also offer insights into GoodRx's compensation practices.
Stakeholder Impact
- Shareholders may view the director's stock acquisition as a positive signal.
- Employees may see it as a sign of stability and confidence in the company's leadership.
Key Dates
| Date | Description |
|---|---|
| 07/08/2024 | Date of transaction: Acquisition of 2,464 shares of Class A Common Stock. |
| 06/06/2025 | Earliest vesting date for restricted stock units. |
| 2025 Annual Meeting of Stockholders | Alternative vesting date for restricted stock units. |
| 07/10/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.